Immuno-Mycologics, Inc recalls Immy
Neutralization Buffer may contain contaminants
- General Purpose Reagent
- Under Investigation by firm
The FDA has posted 6 enforcement recalls of general purpose reagent devices since 2025, none of them Class I (most serious). Most recent report: May 6, 2026.
Neutralization Buffer may contain contaminants
Treatment reagent functionality in respiratory specimens liquification cannot be guaranteed.
Treatment reagent functionality in respiratory specimens fluidification cannot be guaranteed.
Distribution without premarket approval/clearance.
Potential for shorter clotting times in clotting tests which have a dilution, leading to possible overestimate of around 1%
transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions.…
Source: U.S. FDA openFDA device enforcement reports, updated continuously. Device type per the FDA's RES classification (“General Purpose Reagent”). Informational only — verify against the FDA before acting.